Blog - Page 2835 of 5597

FridayOct 25, 2013 2:12 pm

Green Automotive Company (GACR) Names Two New Board Members

Green Automotive Company announced earlier today the recruitment of two business leaders, Peter C. Leeds and Carter Read to its Board of Directors. “We are extremely pleased to add these incredible talents to our company’s board,” stated CEO of Green Automotive Company, Ian Hobday. “Throughout each of their successful careers, both Peter and Carter have demonstrated the highest levels of leadership, vision and sound judgment.” A well-known businessman, Peter C. Leeds solidified his reputation as a successful promoter and manager of music icons such as Blondie, Roberta Flack, and Les McCann. Following his impressive music industry career, Leeds erected a…

FridayOct 25, 2013 2:05 pm

Cardium Therapeutics, Inc.’s (CXM) Generx® Addresses Global Cardiac Threat with Revolutionary Potential

Cardium Therapeutics has developed a unique portfolio of businesses and product opportunities in the fields of health sciences and regenerative medicine. Among other opportunities in its portfolio, the company’s lead clinical development product candidate, Generx®, is being developed to treat patients with advanced coronary artery disease (CAD). The market for this disease is tremendous – in 2012, CAD was the most common cause of death in the world, according to the World Health Organization. While healthy lifestyle changes greatly reduce the risk and prominence of CAD, it remains a significant medical challenge worldwide and is especially an issue in markets…

FridayOct 25, 2013 2:03 pm

MMRGlobal, Inc. (MMRF) Video Chart for Friday, October 25, 2013

The MMRF chart is sitting on a strong support level at 2.5 cents. The indicators are showing signs of a swing towards bullishness as the 50 day moving average converges with the pps, putting the chart in a position to try and make a strong move. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

FridayOct 25, 2013 1:59 pm

Boston Therapeutics, Inc. (BTHE) and America’s Sugar Monster

The formal description for Boston Therapeutics is of a pharmaceutical company focused on the development of novel compounds based on complex carbohydrate chemistry to address unmet medical needs in diabetes. But the company’s potential, as an investment and in terms of its possible effect on the tens of millions of people with Type 2 diabetes, is far more dramatic. CEO David Platt is blunt about it, saying in a recent interview with the New Hampshire Union Leader that “We believe that what we have in our hands is an absolute blockbuster.” The blockbuster in question is the company’s one-of-a-kind proprietary…

FridayOct 25, 2013 1:57 pm

ARRAYit Corp. (ARYC) Receives Purchase Order from University of California for Life Science Products

ARRAYit, a life science technology company engaged in the development, manufacture and marketing of life science tools and integrated systems, has received from the University of California a $104,000 purchase order for the company’s life science instruments product line. The University of California is one of the nation's most prestigious educational and research systems comprising 442,000 students and employees scattered across 10 campuses, and has an investment portfolio of retirement, endowment and cash assets of $78.5 billion. ARYC said it will book the recent sale to the University of California as revenue and earnings in the current quarter. In addition…

FridayOct 25, 2013 10:36 am

Tonix Pharmaceuticals (TNXP) to Help Raise Fibromyalgia Awareness through Partnership with America Chronic Pain Association

Development-stage specialty pharmaceutical company Tonix Pharmaceuticals Holding Corp. announced it has become a corporate partner of the American Chronic Pain Association (ACPA) as part of that organization’s efforts to raise awareness about fibromyalgia, a syndrome increasingly identified in people who suffer chronic pain and believed to affect around 5 million people in the United States. Currently, Tonix is developing TNX-102 SL, its lead clinical candidate for treating fibromyalgia and post-traumatic stress disorder. Tonix recently announced the initiation of the BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT) clinical trial – the first of two anticipated pivotal trials for TNX-102…

FridayOct 25, 2013 10:35 am

Raptor Resources Holdings, Inc. (RRHI) Poised for Success through Two Unique Subsidiaries

As a holdings company focused on mineral resource acquisition, exploration and development, Raptor Resources Holdings operates through two subsidiaries: Mabwe Minerals, Inc. (MBMI) and TAG Minerals, Inc. Raptor Resources’ aim is to grow both organically and through acquiring seasoned mining and mineral assets. Mabwe Minerals is a fully reporting, publicly traded natural resources and hard asset company dedicated to industrial minerals and metals mining and commercial sales. The parent company’s efforts have been focused on Mabwe Minerals for the past two years as it endeavors to move into commercial barite production. Operations are conducted through Mabwe Corporation Limited, the company’s…

FridayOct 25, 2013 10:35 am

JetPay Corp. (JTPY) Payroll Services Expands Payroll, Tax Filing and More to Lancaster County, PA

JetPay’s subsidiary, JetPay® Payroll Services, announced today that it is expanding its state-of-the-art payroll, tax filing, and human resource services to businesses in Lancaster County, Pennsylvania. JetPay Payroll will be allocating staff and resources to businesses in Lancaster County, and has expanded its products and services to meet the specific needs of enterprises in that area. With a 40-year presence in the Lehigh Valley, JetPay Payroll Services (formerly A.D. Computer) has been recognized for its award-winning customer service and innovative technology platform. JetPay has one of the most complete payments platforms in the country with mobile payments, Internet payments, and…

FridayOct 25, 2013 10:34 am

CytRx (CYTR) to Present Global Phase 2b Clinical Data for Aldoxorubicin at Annual Connective Tissue Oncology Society Meeting

Oncology-focused biopharmaceutical research and development company CytRx Corporation announced it will present additional preliminary data from its Phase 2b clinical trial – demonstrating aldoxorubicin’s potential advantage over doxorubicin in treating soft tissue sarcoma (STS) – at the 18th Annual Connective Tissue Oncology Society (CTOS) Meeting, taking place Thursday, Oct. 31 in the Sheraton New York Times Square Hotel. CytRx previously reported that patients in the trial who were treated with aldoxorubicin had an overall response rate (ORR) of 22 percent, as opposed to those administered the widely used chemotherapeutic agent doxorubicin, who had an ORR of 0 percent. CytRx plans…

FridayOct 25, 2013 10:32 am

Bridgeline Digital, Inc. (BLIN) Debuts New eCommerce Store for National School Supplies Company on the iAPPS Commerce Platform

Bridgeline Digital, Inc. (Nasdaq:BLIN), The Digital Engagement Company™, announced earlier today that a leading provider of both innovative and cost efficient writing supplies for offices, schools and homes has launched their new eCommerce web store on Bridgeline Digital's iAPPS Commerce platform. Catering to office administrators, teachers and parents, the newly developed web store allows their corporate marketing team to manage and control digital engagement efforts alongside eCommerce strategies in a single, unified framework. With nationwide eCommerce sales increasing and expected to reach an impressive $262 billion come the end of 2013, the company felt it was crucial to improve the…

Site Search

Company Search